IDEAYA Biosciences, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6.6M | 10.9M | 207.8M | 0 | 0 | 7.0M | 0 | 0 |
| Cost of Goods Sold | 1.1M | 0 | 0 | 0 | 0 | 643K | 1.0M | 1.1M |
| Gross Profit | 5.4M | 10.9M | 207.8M | 0 | 0 | 6.4M | -1.0M | -1.1M |
| R&D Expenses | 95.7M | 86.6M | 83.0M | 74.2M | 70.9M | 140.2M | 57.2M | 54.5M |
| Operating Expenses | 114.0M | 105.4M | 99.4M | 88.8M | 84.4M | 150.5M | 65.9M | 63.8M |
| Operating Income | -108.5M | -94.6M | 108.5M | -88.8M | -84.4M | -144.1M | -66.9M | -64.9M |
| Other Income / Gains | 10.0M | 11.3M | 10.8M | 11.3M | 13.0M | 13.8M | 15.1M | 12.2M |
| Net Income | -98.5M | -83.3M | 119.2M | -77.5M | -71.4M | -130.3M | -51.8M | -52.8M |
| EPS (Diluted) | -1.11 | -0.94 | 1.35 | -0.88 | -0.82 | -1.49 | -0.60 | -0.68 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.826 | 1.00 | 1.00 | 0 | 0 | 0.908 | 0 | 0 |
| General And Administrative Expenses | 19.4M | 18.8M | 16.4M | 14.6M | 13.5M | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 19.4M | 18.8M | 16.4M | 14.6M | 13.5M | 10.3M | 8.7M | 9.3M |
| Other Expenses | -1.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 115.1M | 105.4M | 99.4M | 88.8M | 84.4M | 151.1M | 66.9M | 64.9M |
| Interest Income | 10.0M | 11.3M | 10.8M | 11.3M | 12.2M | 13.8M | 15.1M | 12.2M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 1.1M | 1.2M | 1.0M | 1.2M | 1.1M | 643K | 1.0M | 1.1M |
| Ebitda | -107.4M | -93.4M | 109.5M | -87.6M | -83.3M | -129.7M | -50.8M | -51.7M |
| Ebitdaratio | -16.372 | -8.585 | 0.527 | 0 | 0 | -18.524 | 0 | 0 |
| Operating Income Ratio | -16.546 | -8.695 | 0.522 | 0 | 0 | -20.591 | 0 | 0 |
| Income Before Tax | -98.5M | -83.3M | 119.2M | -77.5M | -71.4M | -130.3M | -51.8M | -52.8M |
| Income Before Tax Ratio | -15.021 | -7.657 | 0.574 | 0 | 0 | -18.616 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -15.021 | -7.657 | 0.574 | 0 | 0 | -18.616 | 0 | 0 |
| Epsdiluted | -1.11 | -0.94 | 1.33 | -0.88 | -0.82 | -1.49 | -0.60 | -0.68 |
| Weighted Average Shs Out | 88.7M | 88.6M | 89.7M | 88.5M | 88.4M | 87.3M | 86.2M | 78.0M |
| Weighted Average Shs Out Dil | 88.7M | 88.6M | 89.7M | 88.5M | 88.4M | 87.3M | 86.2M | 78.0M |